, id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,6533,179,Comparative Toxicogenomics Database (CTD),Acetoin,D000093,Acetoin,https://ctdbase.org/detail.go?type=chem&acc=D000093,231,AKR1B1,https://ctdbase.org/detail.go?type=gene&acc=231,,,231,AKR1B1,9606,Homo sapiens (human),"[AKR1B1 protein results in increased reduction of diacetyl] which results in increased chemical synthesis of acetoin|akr1b1 protein results in increased reduction of acetoin|[akr1b1 protein results in increased reduction of acetoin] which results in increased chemical synthesis of 2,3-butylene glycol",,,PMID:23295224,https://www.ncbi.nlm.nih.gov/pubmed/23295224,23295224.0,,
1,6725,179,Comparative Toxicogenomics Database (CTD),Acetoin,D000093,Acetoin,https://ctdbase.org/detail.go?type=chem&acc=D000093,57016,AKR1B10,https://ctdbase.org/detail.go?type=gene&acc=57016,,,57016,AKR1B10,9606,Homo sapiens (human),"AKR1B10 protein results in increased reduction of acetoin|[akr1b10 protein results in increased reduction of acetoin] which results in increased chemical synthesis of 2,3-butylene glycol|[akr1b10 protein results in increased reduction of diacetyl] which results in increased chemical synthesis of acetoin",,,PMID:23295224,https://www.ncbi.nlm.nih.gov/pubmed/23295224,23295224.0,,
2,6726,179,Comparative Toxicogenomics Database (CTD),Acetoin,D000093,Acetoin,https://ctdbase.org/detail.go?type=chem&acc=D000093,51181,DCXR,https://ctdbase.org/detail.go?type=gene&acc=51181,,,51181,DCXR,9606,Homo sapiens (human),"9,10-phenanthrenequinone inhibits the reaction [[[DCXR protein co-treated with NAD] results in increased reduction of diacetyl] which results in increased chemical synthesis of acetoin]|1,2-naphthoquinone inhibits the reaction [[[DCXR protein co-treated with NAD] results in increased reduction of diacetyl] which results in increased chemical synthesis of acetoin]|vitamin K 3 inhibits the reaction [[[DCXR protein co-treated with NAD] results in increased reduction of diacetyl] which results in increased chemical synthesis of acetoin]|[dcxr protein co-treated with NAD] results in increased chemical synthesis of acetoin|[[dcxr protein co-treated with NAD] results in increased reduction of diacetyl] which results in increased chemical synthesis of acetoin|1,4-naphthoquinone inhibits the reaction [[[DCXR protein co-treated with NAD] results in increased reduction of diacetyl] which results in increased chemical synthesis of acetoin]",,,PMID:28595002,https://www.ncbi.nlm.nih.gov/pubmed/28595002,28595002.0,,
3,13485,179,Therapeutic Target Database (TTD),Acetoin,D00NDF,3-Hydroxy-2-butanone,https://idrblab.net/ttd/data/drug/details/D00NDF,T83011,Monoamine oxidase type B (MAO-B),https://idrblab.net/ttd/data/target/details/T83011,P27338,Amine oxidase [flavin-containing] B,4129,MAOB,9606,Homo sapiens (human),Inhibitor,,,,,,,
